← FDA Drug Approvals (Drugs@FDA)

MIRTAZAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2025-10-02

Drug application

FDA Application #
ANDA219721
Application type
Abbreviated New Drug Application (Generic)
Brand name
MIRTAZAPINE
Generic name
MIRTAZAPINE
Active ingredients
MIRTAZAPINE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
ANNORA PHARMA
Manufacturer
Camber Pharmaceuticals, Inc.
First approval
2025-10-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown